BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2026 8:18:31 AM | Browse: 5 | Download: 39
 |
Received |
|
2026-01-07 03:33 |
|
Peer-Review Started |
|
2026-01-07 03:33 |
|
First Decision by Editorial Office Director |
|
2026-01-16 06:53 |
|
Return for Revision |
|
2026-01-16 06:53 |
|
Revised |
|
2026-01-29 11:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-13 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-13 05:48 |
|
Articles in Press |
|
2026-02-13 05:48 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-24 02:12 |
|
Publish the Manuscript Online |
|
2026-05-13 08:18 |
| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Observational Study |
| Article Title |
Study on intravenous immunoglobulin use in a pediatric intensive care unit of a tertiary care center
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Poovazhagi Varadarajan, Seenivasan Subramani, Vasanth Jeyaram, Lakshmi S Velmurugan, Raghul Jayaseelan and Gomathy Srividya Venugopal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Seenivasan Subramani, Assistant Professor, Consultant, DM, Department of Pediatric Intensive Care, Institute of Child Health and Hospital for Children, Madras Medical College, Tamil Salai, Egmore Chennai, Chennai 600008, Tamil Nādu, India. seeni.sholing@gmail.com |
| Key Words |
Intravenous immunoglobulin; Pediatric intensive care unit; Off label use; Strength of recommendation; Level of evidence |
| Core Tip |
This study evaluates intravenous immunoglobulin (IVIG) use in a pediatric intensive care unit, highlighting indications, dosing, evidence support, and outcomes. The commonest indication was immunological diseases followed by neurological illness, infections, hematological diseases and cardiac diseases. Strength of recommendation varies in different diseases. Off label use was seen in about one -fifth of patients. Adverse effects were minimal. Evidence is lacking regarding the use of IVIG in many diseases. The study suggests multicentric trials to define proper indications of IVIG. |
| Publish Date |
2026-05-13 08:18 |
| Citation |
Varadarajan P, Subramani S, Jeyaram V, Velmurugan LS, Jayaseelan R, Venugopal GS. Study on intravenous immunoglobulin use in a pediatric intensive care unit of a tertiary care center. World J Clin Pediatr 2026; 15(2): 118421 |
| URL |
https://www.wjgnet.com/2219-2808/full/v15/i2/118421.htm |
| DOI |
https://dx.doi.org/10.5409/wjcp.v15.i2.118421 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
